$3.880
+0.010 (+0.26%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de APUS por análisis de gráficos similares
Alphio's APUS stock price prediction model matches the current Apimeds Pharmaceuticals US Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.51 (-0.79%). The 1-week path is $3.80 (+7.43%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Apimeds Pharmaceuticals US Inc?
Given the current price of 3.87, the RSI of 30.157 indicates that the stock is oversold, but the significant year-to-date change of -97.68% and negative net income figures suggest that the company is struggling financially. The recent leadership changes and settlement agreements may provide some hope for recovery, but the risks are substantial, particularly with a projected trajectory indicating a potential future change of +243.47% based on historical patterns, which is speculative at best. The main risk is the company's current liabilities exceeding its assets, leading to a current ratio of 0.00.
APUS cerró en $3.88 el Monday, tras subir +0.26%
Apimeds Pharmaceuticals US Inc (APUS) last closed at $3.54, losing -8.76%. These facts feed the 1-day and 1-week APUS price prediction above.
Factores de la previsión
Los factores de la previsión de Apimeds Pharmaceuticals US Inc (APUS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de APUS, ordenadas por similitud.
Análisis de estacionalidad de APUS
Historically the probability of a positive September return for APUS is 0.00%. January offers the highest probability of a positive month at 75.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de APUS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $1.30 | $1.58 | $1.73 | -55.38% |
| Oct 2026 | $1.58 | $1.66 | $2.13 | -53.13% |
| Nov 2026 | $1.80 | $2.14 | $2.61 | -39.63% |
| Dec 2026 | $1.92 | $1.96 | $2.05 | -44.59% |
En 2026, se proyecta que Apimeds Pharmaceuticals US Inc (APUS) oscile entre $1.30 y $2.61.
Previsión mensual de Apimeds Pharmaceuticals US Inc para 2026
En Sep de 2026, se proyecta que Apimeds Pharmaceuticals US Inc promedie $1.58, con un mínimo de $1.30 y un máximo de $1.73.
En Oct de 2026, se proyecta que Apimeds Pharmaceuticals US Inc promedie $1.66, con un mínimo de $1.58 y un máximo de $2.13.
En Nov de 2026, se proyecta que Apimeds Pharmaceuticals US Inc promedie $2.14, con un mínimo de $1.80 y un máximo de $2.61.
En Dec de 2026, se proyecta que Apimeds Pharmaceuticals US Inc promedie $1.96, con un mínimo de $1.92 y un máximo de $2.05.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.